These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16113)

  • 1. Solubility studies of silver sulfadiazine.
    Nesbitt RU; Sandmann BJ
    J Pharm Sci; 1977 Apr; 66(4):519-22. PubMed ID: 16113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility studies of silver sulfonamides.
    Nesbitt RU; Sandmann BJ
    J Pharm Sci; 1978 Jul; 67(7):1012-7. PubMed ID: 26788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, physical properties and microbiological activities of more water soluble silver sulfadiazine derivatives.
    De Wit PP; Van Doorne H; Bult A
    Pharm Weekbl Sci; 1983 Dec; 5(6):298-301. PubMed ID: 6664822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of adenosine triphosphatase in vitro by silver nitrate and silver sulfadiazine.
    Nechay BR; Saunders JP
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):119-26. PubMed ID: 6240533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the specified impurities of silver sulfadiazine using a screening of degradation products in different stress physico-chemical media.
    Cioroiu BI; Lazar MI; Bello-López MA; Fernandez-Torres R
    Talanta; 2013 Nov; 116():653-62. PubMed ID: 24148458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate.
    Saffer LD; Rodeheaver GT; Hiebert JM; Edlich RF
    Surg Gynecol Obstet; 1980 Aug; 151(2):232-6. PubMed ID: 6773164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of silver and cerium in the liver and the kidney from a severely burned infant treated with silver sulfadiazine and cerium nitrate].
    Hirakawa K
    Radioisotopes; 1983 Feb; 32(2):59-65. PubMed ID: 6867381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of in vitro sensitivity to sulfadiazine silver.
    McManus AT; Denton CL; Mason AD
    Arch Surg; 1983 Feb; 118(2):161-6. PubMed ID: 6401421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical chemotherapy for burns using cerium salts and silver sulfadiazine.
    Fox CL; Monafo WW; Ayvazian VH; Skinner AM; Modak S; Stanford J; Condict C
    Surg Gynecol Obstet; 1977 May; 144(5):668-72. PubMed ID: 850849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum and tissue silver levels after burns treated with silver compounds].
    Kartal A; Tatkan Y; Belviranli M; Sahin M; Duman S; Karahan O; Gurbilek M; Temur S
    J Chir (Paris); 1989 Dec; 126(12):676-81. PubMed ID: 2621235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM; Fox CL
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patch testing with silver sulfadiazine cream.
    Degreef H; Dooms-Goossens A
    Contact Dermatitis; 1985 Jan; 12(1):33-7. PubMed ID: 3979042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of nicardipine hydrochloride via complexation and salt formation.
    Maurin MB; Rowe SM; Koval CA; Hussain MA
    J Pharm Sci; 1994 Oct; 83(10):1418-20. PubMed ID: 7884662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective, randomized study.
    Helvig EI; Munster AM; Su CT; Oppel W
    Am Surg; 1979 Apr; 45(4):270-2. PubMed ID: 434623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and urinary silver levels in thermal injury patients.
    Boosalis MG; McCall JT; Ahrenholz DH; Solem LD; McClain CJ
    Surgery; 1987 Jan; 101(1):40-3. PubMed ID: 3798326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-solubility profiles or organic carboxylic acids and their salts.
    Chowhan ZT
    J Pharm Sci; 1978 Sep; 67(9):1257-60. PubMed ID: 29115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine].
    Maitre S; Jaber K; Perrot JL; Guy C; Cambazard F
    Ann Dermatol Venereol; 2002 Feb; 129(2):217-9. PubMed ID: 11937961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcomputer-controlled determination of dissociation constants of sulfanilamides and stability constants of the related silver complexes.
    Boelema GJ; Bult A; Metting HJ; Bajema BL; Doornbos DA
    Pharm Weekbl Sci; 1982 Apr; 4(2):38-42. PubMed ID: 7099913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of mixed counter ion on saturation solubility of esylate salt of a weak basic drug to formulate physically stable and non-hemolytic ready to use injectable solution.
    Dalwadi G; Sun Y; Wang L; Shick J; Hicks K; Lam S; Tuliani V; Patel K
    Int J Pharm; 2019 Dec; 572():118829. PubMed ID: 31715348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: a double-blind, clinical study.
    Koller J
    Drugs Exp Clin Res; 2004; 30(5-6):183-90. PubMed ID: 15700744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.